Daily versus post-dialysis administration of calcimimetics for the treatment of secondary hyperparathyroidism in haemodialysis patients: an interventional, multi-centre study [article retracted]

Auteurs

  • Tarek M Demerdash
  • Mostafa Abdelsalam
  • Mohammed Assem
  • Mahmoud M Shaheen
  • Mohamed A Marie kasalainy school of medicine ,Cairo university

DOI :

https://doi.org/10.21804/23-1-3728

Résumé

This article has been retracted.


The retraction notice was published on 06 May 2020: 
Retraction notice: Daily versus post-dialysis administration of calcimimetics for the treatment of secondary hyperparathyroidism in haemodialysis patients: an interventional, multi-centre study. Afr J Nephrol. 2020; 2391):85.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Téléchargements

Publiée

2020-04-25

Comment citer

Demerdash, Tarek M, Mostafa Abdelsalam, Mohammed Assem, Mahmoud M Shaheen, et Mohamed A Marie. 2020. « Daily Versus Post-Dialysis Administration of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Haemodialysis Patients: An Interventional, Multi-Centre Study [article Retracted] ». African Journal of Nephrology 23 (1):81-84. https://doi.org/10.21804/23-1-3728.

Numéro

Vol. 23 No 1 (2020)

Rubrique

Original articles